| Reference |
|---|
Reuschl A, Thorne L, Whelan M, Ragazzini R, Furnon W, Cowton V, et al. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants. Nat Microbiol. 2024;9:451-463 pubmed publisher |
De M, Sukla S, Bharatiya S, Keshri S, Roy D, Roy S, et al. IFN-λ3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans. Infect Immun. 2024;92:e0050423 pubmed publisher |
Schutt W, Conde J, Mladinich M, Himmler G, Mackow E. ZIKV induction of tristetraprolin in endothelial and Sertoli cells post-transcriptionally inhibits IFNβ/λ expression and promotes ZIKV persistence. MBio. 2023;14:e0174223 pubmed publisher |
Sugimoto A, Numaguchi T, Chihama R, Takenaka Y, Sato Y. Identification of novel lactic acid bacteria with enhanced protective effects against influenza virus. PLoS ONE. 2023;18:e0273604 pubmed publisher |
St xf6 lting H, Baillon L, Frise R, Bonner K, Hewitt R, Molyneaux P, et al. Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1. Mucosal Immunol. 2022;15:952-963 pubmed publisher |
Gibson A, Sateriale A, Dumaine J, Engiles J, Pardy R, Gullicksrud J, et al. A genetic screen identifies a protective type III interferon response to Cryptosporidium that requires TLR3 dependent recognition. PLoS Pathog. 2022;18:e1010003 pubmed publisher |
Steiner A, Hrovat Schaale K, Prigione I, Yu C, Laohamonthonkul P, Harapas C, et al. Deficiency in coatomer complex I causes aberrant activation of STING signalling. Nat Commun. 2022;13:2321 pubmed publisher |
Song Y, Hou G, Diep J, Ooi Y, Akopyants N, Beverley S, et al. Inhibitor of growth protein 3 epigenetically silences endogenous retroviral elements and prevents innate immune activation. Nucleic Acids Res. 2021;49:12706-12715 pubmed publisher |
Oh S, Shin O. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response. Cells. 2021;10: pubmed publisher |
Hendricks M, Lane S, Melvin J, Ouyang Y, Stolz D, Williams J, et al. Extracellular vesicles promote transkingdom nutrient transfer during viral-bacterial co-infection. Cell Rep. 2021;34:108672 pubmed publisher |
Hjorton K, Hagberg N, Pucholt P, Eloranta M, Rönnblom L. The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cells. Arthritis Res Ther. 2020;22:130 pubmed publisher |
Alam J, Lee A, Lee J, Kwon D, Park H, Park J, et al. Dysbiotic oral microbiota and infected salivary glands in Sjögren's syndrome. PLoS ONE. 2020;15:e0230667 pubmed publisher |
Xu H, Xu S, Xie S, Zhang Y, Yang J, Zhang W, et al. MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway. elife. 2019;8: pubmed publisher |
Niwa M, Fujisawa T, Mori K, Yamanaka K, Yasui H, Suzuki Y, et al. IL-17A Attenuates IFN-? Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium. J Immunol. 2018;: pubmed publisher |
Colavita F, Bordoni V, Caglioti C, Biava M, Castilletti C, Bordi L, et al. ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMC. Mediators Inflamm. 2018;2018:2450540 pubmed publisher |
Ding S, Diep J, Feng N, Ren L, Li B, Ooi Y, et al. STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection. Nat Commun. 2018;9:1485 pubmed publisher |
Ueno N, Nishimura N, Ueno S, Endo S, Tatetsu H, Hirata S, et al. PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4. Oncogene. 2017;36:4481-4497 pubmed publisher |
Akoto C, Davies D, Swindle E. Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations. Clin Exp Allergy. 2017;47:351-360 pubmed publisher |
Telcian A, Zdrenghea M, Edwards M, Laza Stanca V, Mallia P, Johnston S, et al. Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro. Antiviral Res. 2017;137:93-101 pubmed publisher |
Lalle E, Bordi L, Caglioti C, Garbuglia A, Castilletti C, Taibi C, et al. IFN-Alpha receptor-1 upregulation in PBMC from HCV naïve patients carrying cc genotype. possible role of IFN-lambda. PLoS ONE. 2014;9:e93434 pubmed publisher |
Dolganiuc A, Kodys K, Marshall C, Saha B, Zhang S, Bala S, et al. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells. PLoS ONE. 2012;7:e44915 pubmed publisher |
Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, et al. Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells. J Immunol. 2012;189:2735-45 pubmed publisher |
Bierne H, Travier L, Mahlakõiv T, Tailleux L, Subtil A, Lebreton A, et al. Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta. PLoS ONE. 2012;7:e39080 pubmed publisher |
Popugaeva E, Witkowski P, Schlegel M, Ulrich R, Auste B, Rang A, et al. Dobrava-Belgrade hantavirus from Germany shows receptor usage and innate immunity induction consistent with the pathogenicity of the virus in humans. PLoS ONE. 2012;7:e35587 pubmed publisher |
Donnelly O, Errington Mais F, Steele L, Hadac E, Jennings V, Scott K, et al. Measles virus causes immunogenic cell death in human melanoma. Gene Ther. 2013;20:7-15 pubmed publisher |
Sancho Shimizu V, Pérez de Diego R, Lorenzo L, Halwani R, Alangari A, Israelsson E, et al. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest. 2011;121:4889-902 pubmed publisher |
Zahn S, Rehkämper C, Kummerer B, Ferring Schmidt S, Bieber T, Tüting T, et al. Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFN?) in cutaneous lupus erythematosus. J Invest Dermatol. 2011;131:133-40 pubmed publisher |
Pietila T, Latvala S, Osterlund P, Julkunen I. Inhibition of dynamin-dependent endocytosis interferes with type III IFN expression in bacteria-infected human monocyte-derived DCs. J Leukoc Biol. 2010;88:665-74 pubmed publisher |
Stoltz M, Klingstrom J. Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection. J Virol. 2010;84:9140-8 pubmed publisher |
Krausgruber T, Saliba D, Ryzhakov G, Lanfrancotti A, Blazek K, Udalova I. IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood. 2010;115:4421-30 pubmed publisher |
Megjugorac N, Gallagher G, Gallagher G. IL-4 enhances IFN-lambda1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra. Blood. 2010;115:4185-90 pubmed publisher |
Wang Q, Nagarkar D, Bowman E, Schneider D, Gosangi B, Lei J, et al. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol. 2009;183:6989-97 pubmed publisher |
Wolk K, Witte K, Witte E, Proesch S, Schulze Tanzil G, Nasilowska K, et al. Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J Leukoc Biol. 2008;83:1181-93 pubmed publisher |
